Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenue	$ 7	$ 13
Operating expenses:
Research and development	165	309
Management contingent share plan	33	764
Selling, general and administrative	988	6,332
Total operating expenses	1,186	7,405
Loss from operations	(1,179)	(7,392)
Change in fair value of warrant liabilities	8
Interest expense	(301)	(225)
Other expense	(32)	(22)
Total non-operating expenses	(325)	(247)
Loss before income taxes	(1,504)	(7,639)
Provision for income taxes
Net loss	(1,504)	(7,639)
Deemed dividend from trigger of down round provisions and extension of Assumed Warrants	(656)
Net loss to common stockholders	$ (2,160)	$ (7,639)
Class A Common Stock
Operating expenses:
Net loss per Class A Common Stock, basic (in Dollars per share)	$ (0.24)	$ (3.3)
Basic weighted average number of Class A Common Stock (in Shares)	8,918,000	2,315,000